Hence, the therapeutic effect of sacubitril/valsartan, compared with angiotensin receptor blockers or ACE inhibitors alone, vary according to the left ventricle ejection fraction (CHF with reduced or mildly reduced ejection fraction) [31, 32]. The gene discussed is ACE; the disease is congestive heart failure.